|
|
|
| Bharat Bio launches first indigenous single-shot against 5 diseases | 02-MAR-09 |
|
| Bharat Biotech International Limited, a Hyderabad-based manufacturer of vaccines and biotherapeutics, on Monday launched COMVAC5, a single-shot pentavalent combination vaccine which contains the first indigenously developed and manufactured haemophilus influenza type-b (Hib) vaccine in India and the only Hepatitis B vaccine in the world to be manufactured without the use of cesium chloride. |
|
|
|
| Shantha plans 3 new vaccines | 31-AUG-06 |
|
| Shantha Biotechnics Private Ltd, a Rs 90 crore company, is progressing with its new expansion plans to introduce DTP, Hepatitis B and BIB pentavalent vaccines by the end of current calendar year.
|
|
|
|
| Bristol-Myers rolls out hepatitis B drug | 12-JUL-06 |
|
| Bristol-Myers Squibb (BMS) India, the wholly owned subsidiary of the $19.2 billion US pharmaceutical company, has launched Baraclude, its anti-Hepatitis B drug in India.
|
|
|
|
| Transgene completes oral insulin, Hep B delivery | 08-DEC-05 |
|
| Transgene Biotek Limited has informed that the company has completed the development of oral delivery of insulin and of Hepatitis B vaccine in collaboration with the pharmacology division led by |
|
|
|
| Wockhardt to focus on freer mkts | 07-JUN-05 |
|
| Over the next two years Wockhardt will strive to focus heavily on less-regulated markets for growth and it plans to release three more biotech products.
|
|
|
|
|
|
|
| IIL opens plant in Hyderabad | 06-OCT-03 |
|
| Indian Immunologicals Ltd (IIL), the wholly owned subsidiary of the National Dairy Development Board (NDDB), opened its state-of-the-art human vaccines plant and research & development (R&D) |
|
|
|
| IIL opens plant in Hyderabad | 06-OCT-03 |
|
| Indian Immunologicals Ltd (IIL), the wholly owned subsidiary of the National Dairy Development Board (NDDB), opened its state-of-the-art human vaccines plant and research & development (R&D) |
|
|
|
|
|
|
|
|
|
Content Guide
